Xtl Biopharmaceuticals

Protein therapeutics for inflammatory diseases such as systemic lupus erythematosus and multiple myeloma.

placeRa Anana, Center District, Israel calendar_todayFounded 1993 groups4 employees language xtlbio.com

Innovation

15 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 231 times.

YearFilings
20122
20182
20201

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Bank & private debt120%
Other / undisclosed120%
Coming soon